Collective Family Office’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,348
Closed -$206K 195
2022
Q1
$206K Buy
+2,348
New +$203K 0.08% 186

Other funds holding NVS

Collective Family Office's NVS Position: Q2 2022 in Review

Collective Family Office sold out of Novartis (NVS) in Q2 2022, closing a stake of 2,348 shares — an estimated $206K sold.

Collective Family Office first reported a position in NVS in Q1 2022 and held it in 1 quarter. The position peaked at $206K in Q1 2022. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

  • Collective Family Office reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
  • Collective Family Office sold 2,348 Novartis shares in Q2 2022, an estimated $206K.
  • Collective Family Office first reported a position in Novartis in Q1 2022 and held it in 1 quarter.
  • Collective Family Office's Novartis position peaked at $206K in Q1 2022.
  • 1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Collective Family Office's 13F filing for Q2 2022, filed 18 Jul 2022.